Letter to the Editor
Is Umbilical Cord Ulcer Associated with Congenital Upper Intestinal Atresia So Rare? Japanese Case Series and Review of the LiteratureOhyama M.a · Itani Y.a · Ishikawa H.b · Tanaka Y.c
aDepartment of Neonatology, bObstetrics and cPathology, Kanagawa Children’s Medical Center, Yokohama, Japan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
- Kimura T, Usui N, Kamata S, Kawahara H, Sawai T, Hirano S, Wada K, Tomimatsu T, Fukuda H, Okada A: Umbilical cord ulcer associated with fetal jejunal atresia: report of 2 cases. Fetal Diag Ther 2003;18:144–147.
- Miyake H, Yamamoto A, Yamada T, Okazaki K, Morita K, Kondo M, Ishida T, Nishina T, Yokota A, Nakai A, Takeshita T: Umbilical cord ulceration after prenatal diagnosis of duodenal atresia with interstitial deletion of chromosome 13q: a case report. Fetal Diag Ther 2008;24:115–118.
- Bendon RW, Tyson RW, Baldwin VJ, Cashner KA, Mimouni F, Miodovnik M: Umbilical cord ulceration and intestinal atresia: a new association? Am J Obstet Gynecol 1991;164:582–586.
- Khong TY, Ford WDA, Haan EA: Umbilical cord ulceration in association with intestinal atresia in a child with deletion 13q and Hirschsprung’s disease. Arch Dis Child 1994;71:F212–F213.
- Khurana A, Huettner PC, Cole FS: Umbilical cord ulceration as a cause of hypoxic-ischemic encephalopathy: report of a case and review of the literature. J Perinatol 1995;15:423–425.
Chan SS, Lau AP, To KF, Leung TY, Lau TK, Leung TN: Umbilical cord ulceration causing foetal haemorrhage and stillbirth. Hong Kong Med J 2008;14:148–151.
- Nijagal A, Rand L, Goldstein R, Poder L, Miniati D: Intrauterine umbilical cord hemorrhage with associated jejunal atresia captured by real-time ultrasound. Am J Obstet Gynecol 2009;200:e5–e6.
- Yamanaka M, Ohyama M, Koresawa M, Kawataki M, Ohsaki I, Tanaka Y: Umbilical cord ulceration and intestinal atresia. Eur J Obstet Gynecol Reprod Biol 1996;70:209–212.
- Ohyama M, Itani Y, Yamanaka M, Imaizumi K, Nishi T, Ijiri R, Tanaka Y: Umbilical cord ulcer: a serious in utero complication of intestinal atresia. Placenta 2000;21:432–435.
- Anami A, Morokuma S, Tsukimori K, Kondo H, Nozaki M, Sueishi K, Nakano H: Sudden fetal death associated with both duodenal atresia and umbilical cord ulcer: a case report and review. Am J Perinatol 2006;23:183–188.
- Shimizu S, Kawagishi R, Arimoto-Ishida E, Wada K, Shimoya K, Murata Y: Fetal hemorrhage associated with congenital intestinal atresia. J Obstet Gynaecol Res 2007;33:726–730.
- Hidaka N, Chiba Y: Intrauterine hemorrhage from an umbilical cord ulcer associated with fetal duodenal atresia: a case report. Arch Gynecol Obstet 2007;275:219–222.
- Miyachi K, Kikuchi A, Kitsunezaki M, Sunagawa S, Hiroma T, Takagi K, Ogiso Y, Nakamura T: Sudden fetal hemorrhage from umbilical cord ulcer associated with congenital intestinal atresia. J Obstet Gynaecol Res 2007;33:726–730.
Ohyama M: Perinatal diseases recognized by placental examination (in Japanese). Perinatal Med (Tokyo) 2010;40:1015–1022.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.